IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors | MicrobiomeTrials← Back to trialsNCT05039801
IACS-6274 With or Without Bevacizumab and Paclitaxel for the Treatment of Advanced Solid Tumors
RecruitingPHASE1INTERVENTIONAL
Trial Details
Start: 2021-09-30Est. Completion: 2028-03-30
Enrollment target: 54 participants Locations- M D Anderson Cancer Center, Houston, Texas, United States
Other microbiome trials you might be interested in
Endometrial Cancer RecurrentEndometrial CancerAdvanced Endometrial CancerOvarian CancerOvarian Cancer RecurrentPlatinum Resistant Ovarian CancerEndometrial Cancers
The goal of this clinical trial is to learn if OPB-201 is safe in recurrent endometrial and platinum resistant ovarian c…
San Francisco, United StatesEst. completion Jun 2030
Advanced Malignant Solid Neoplasm
Anatomic Stage III Breast Cancer AJCC v8
Anatomic Stage IV Breast Cancer AJCC v8
Locally Advanced Malignant Solid Neoplasm
Malignant Female Reproductive System Neoplasm
Metastatic HER2-Negative Breast Carcinoma
Metastatic Malignant Solid Neoplasm
Recurrent Endometrial Carcinoma
Recurrent Fallopian Tube Carcinoma
Recurrent Malignant Female Reproductive System Neoplasm
Recurrent Malignant Solid Neoplasm
Recurrent Ovarian Carcinoma
Recurrent Primary Peritoneal Carcinoma
Unresectable HER2-Negative Breast Carcinoma
Unresectable Malignant Solid Neoplasm
This ComboMATCH patient screening trial is the gateway to a coordinated set of clinical trials to study cancer treatment…
Birmingham, United StatesEst. completion Jul 1, 2030
Advanced Solid TumorMelanomaHead and Neck CancerGastric CancerOvarian CarcinomaCervical CancerEndometrial CancerBladder CancerEsophageal CancerPancreatic CarcinomaProstate CancerNon-small Cell Lung Cancer (NSCLC)Lung CancerBreast Cancer
This is a proof-of-concept study designed to investigate HER3-DXd monotherapy in locally advanced unresectable or metast…
Duarte, United StatesEst. completion Sep 1, 2027